A Study to Evaluate the Efficacy and Safety of SHR8008 vs. Fluconazole in Subjects With Recurrent Vulvovaginal Candidiasis
Condition: Recurrent Vulvovaginal Candidiasis Interventions: Drug: SHR8008; Drug: Fluconazole Sponsor: Jiangsu HengRui Medicine Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 12, 2021 Category: Research Source Type: clinical trials